Protecting your child from Meningitis B with Bexsero

Why should I vaccinate my child against Meningitis B?

Meningitis B is the leading infectious killer of young children in the UK

Meningitis is a life threatening infection which even if survived can lead to very serious complications including loss of limbs, epilepsy and brain damage  

What happens if my child is older than 2 months at the time of the roll out?

There is a planned 'catch up' program for babies aged 3 and 4 months at the time of roll out but If your child is older than 4 months at the time of the roll out they will not be included in the vaccination program and so will not benefit from the protection offered.

How much protection does Bexsero give my child?

The vaccine, Bexsero, is thought to provide 73% protection against meningitis B. 

Is Bexsero available privately?

The vaccination has been offered privately by GPs for some time, at Southdowns clinic we have vaccinated over 200 children with the Bexsero Meningitis B vaccine.

For more information and Frequently asked questions about Meningitis B you can visit the Meningitis Now website or the NHS website.

The vaccine is given as two injections 2-6 months apart.

Whatever your concerns we can help -  just give us a call on 033 022 02000 or 01243 766447 or use our online booking system.

In February this year, many of us in the medical community were expressing concerns regarding the availability of the Meningitis B vaccine, Bexsero. NICE (the National Institute for Health and Clinical Excellence), the Government agency that advises on the availability of medicine within the NHS had made recommendations that would see Bexsero not being made available on the NHS owing to cost considerations. This was difficult to understand given that the product is licensed for use and that Meningitis B is can be a very serious condition for young children.

We’re delighted therefore that NICE appears to have reconsidered their position in relation to Meningitis B and now it seems will be supporting the Bexsero vaccine as a cost effective way for the NHS to protect all children. Naturally, this will be subject to negotiations on price with the manufacturer. The decision came as a result of further discussion called for and drawing on advice from experts within this field.